Email Us Here

[Pangyo Bio & Medical] SK Bioscience "The Clinical Trial Result of South Korea's First Vaccine to be Released in October"

Kim Hun CTO of SK Bioscience announced the plan explaining the company's future plans of "GBP510," a potential candidate material of covid-19, at "the 18th autumn conference of the Korean Vaccine Society 2021" which was held online.